Menlo Park, CA, United States of America

Health2047, Inc.

Calculating rank
USPTO Granted Patents = 9

Trademarks = 1

Forward Citations = 13

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Charles Aunger (7 out of 9 patents)

silverMedal Jack Stockert (7 out of 9 patents)

bronzeMedal Karl Ronn (3 out of 10 patents)

4.  Doug Given (2 out of 4 patents)

5.  Bernard Pierce Mangold (2 out of 4 patents)

6.  Justin James Klein (2 out of 2 patents)

7.  Adriaan Ligtenberg (1 out of 3 patents)

8.  Tom Frederick (1 out of 3 patents)

9.  Ketan Paranjape (1 out of 3 patents)

10.  Michael Hodgkins (1 out of 3 patents)

11.  Warren Templeton (1 out of 3 patents)

12.  Neile Grayson (1 out of 1 patent)

13.  Roel Nuyts (1 out of 1 patent)

14.  Michael James Walker (1 out of 1 patent)

15.  Josh O Whitkin (1 out of 1 patent)


9 patents:

Company Overview
Health2047 is a Silicon Valley-based innovation catalyst that bridges the gap between healthcare and technology by developing and commercializing promising ideas in the healthcare space. The company focuses on creating solutions for healthcare challenges and improving patient outcomes through collaboration with leading healthcare providers, entrepreneurs, and investors.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

9 Patents

#140 in Menlo Park, CA

#7,751 in California

#32,624 in US

Menlo Park, CA (US)
Menlo Park, CA, United States of America
Forward Citations = 13

17 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Health2047, Inc.. Retrieved from https://idiyas.com/company/health2047

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…